Skip to main content

Advertisement

Table 1 Patient characteristics

From: The association of diabetes mellitus treated with oral antidiabetic drugs and insulin with mortality after transcatheter valve implantation: a 3-year follow-up of the TAVIK registry

  Without diabetes (n = 1337) Diabetes on OAD (n = 387) Diabetes on insulin (n = 276) p-value
Age (years) 82.30 ± 5.51 81.35 ± 5.12 79.75 ± 5.49 < 0.001
Male gender 590 (44.1) 182 (47.0) 140(50.7) 0.110
LVEF (%) 57.57 ± 13.07 56.37 ± 13.77 53.85 ± 14.63 0.001
PAD 187 (14.0) 60 (15.5) 71 (25.7) 0.067
CAD 767 (57.4) 251 (64.9) 199 (72.1) < 0.001
Previous CABG 173 (12.9) 62 (16.0) 68 (24.6) < 0.001
Previous MI 137 (10.2) 49 (12.7) 39 (14.1) 0.110
COPD (moderate/severe) 150 (11.2) 52 (13.4) 33 (12.0) 0.488
Mitral valve disease (> II°) 174 (13.0) 48 (12.4) 38 (13.8) 0.875
Porcelain aorta 88 (6.6) 26 (6.7) 14 (5.1) 0.621
Log. EuroSCORE I 20.46 ± 14.52 20.60 ± 15.12 24.69 ± 18.17 < 0.001
Carotid stenosis 231 (17.3) 74 (19.1) 64 (23.2) 0.065
Previous valve surgery 46 (3.4) 14 (3.6) 5 (1.8) 0.344
Major neurological deficits 128 (9.6) 32 (8.3) 40 (14.5) 0.021
Critical perioperative situation 19 (1.4) 3 (0.8) 6 (2.2) 0.310
Pulmonary hypertension (moderate/severe) 277 (20.7) 68 (17.6) 69 (25.0) 1.0
Renal failure incl. dialysis 53 (4.0) 25 (6.5) 30 (10.9) < 0.001
Emergency case 15 (1.1) 7 (1.8) 6 (2.2) 0.157
Overall frailty 412 (30.8) 141 (36.4) 114 (41.3) 0.001
NYHA IV 88 (6.6) 27 (7.0) 32 (11.6) 0.014
  1. CABG coronary artery bypass graft, CAD coronary artery disease, LVEF left ventricular ejection fraction, MI myocardial infarction, PAD peripheral artery disease, COPD chronic obstructive pulmonary disease